2022 AMERICAN SOCIETY FOR METBOLIC AND BARIATRIC SURGERY (ASMBS) AND INTERNATIONAL FEDERATION FOR THE SURGERY OF OBESITY AND METABOLIC DISORDERS (IFSO): INDICATIONS FOR METABOLIC AND BARIATRIC SURGERY.

2022-11-03T17:13:14+01:00

Contributo di Maurizio De Luca 2022 AMERICAN SOCIETY FOR METBOLIC AND BARIATRIC SURGERY (ASMBS) AND INTERNATIONAL FEDERATION FOR THE SURGERY OF OBESITY AND METABOLIC DISORDERS (IFSO): INDICATIONS FOR METABOLIC AND BARIATRIC SURGERY.

2022 AMERICAN SOCIETY FOR METBOLIC AND BARIATRIC SURGERY (ASMBS) AND INTERNATIONAL FEDERATION FOR THE SURGERY OF OBESITY AND METABOLIC DISORDERS (IFSO): INDICATIONS FOR METABOLIC AND BARIATRIC SURGERY.2022-11-03T17:13:14+01:00

The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss after Bariatric Surgery – a Retrospective Analysis

2022-09-30T15:43:35+02:00

Contributo: De Luca The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss after Bariatric Surgery - a Retrospective Analysis A Lautenbach, M Wernecke,

The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss after Bariatric Surgery – a Retrospective Analysis2022-09-30T15:43:35+02:00

Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection

2022-01-26T17:13:56+01:00

Contributo: Maurizio De Luca Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection Ali Aminian, Chao Tu, Alex Milinovich, Kathy E. Wolski, Michael W. Kattan, Steven E. Nissen JAMA Surg.  December 29, 2021.

Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection2022-01-26T17:13:56+01:00

METABOLIC SURGERY VERSUS CONVENTIONAL MEDICAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES: 10-YEAR FOLLOW-UP OF AN OPEN-LABEL, SINGLE-CENTRE, RANDOMISED CONTROLLED TRIAL.

2021-12-16T19:43:13+01:00

Contributo: Maurizio De Luca METABOLIC SURGERY VERSUS CONVENTIONAL MEDICAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES: 10-YEAR FOLLOW-UP OF AN OPEN-LABEL, SINGLE-CENTRE, RANDOMISED CONTROLLED TRIAL. G Mingrone, S Panunzi, A De Gaetano,

METABOLIC SURGERY VERSUS CONVENTIONAL MEDICAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES: 10-YEAR FOLLOW-UP OF AN OPEN-LABEL, SINGLE-CENTRE, RANDOMISED CONTROLLED TRIAL.2021-12-16T19:43:13+01:00

LOGIN SOCI

Torna in cima